REPROS THERAPEUTICS Community Page | What other sites are saying about REPROS THERAPEUTICS

REPROS THERAPEUTICS

(NQ: RPRX)

19.19 USD +1.26 (+7.03%)

Official Closing Price / Updated: 4:00 PM EDT, Jun 18, 2013 / Add to My Watchlist

(RPRX) Community Analysis from

READ MORE (RPRX)

Bulls REASONS TO BUY

View all Bulls Reasons

Bears REASONS TO SELL

View all Bears Reasons

June 18, 2013

(RPRX) Repros Therapeutics Gets Additional Patents

(Stock Blog Hub, 4/21/13)

Repros Therapeutics Inc. (RPRX) recently announced that two additional patents covering its candidate, Androxal, have been issued. Both patents (8,372,887 and 8,377,991) related...(read more)

RPRX

(Samurai Trader, 8/20/12)

RPRX is a near perfect example of one of the most powerful patterns in the O'Neil arsenal, the high, tight flag. There are certain requirements that O'Neil spells out for this pattern: a very quick 80-100% prior move...(read more)

This Biotech’s Turnaround Will Help it Gain Access to a $20.5 Billion Market

(Investment U, 5/13/11)

It's double the excitement for Repros Therapeutics (Nasdaq: RPRX); the company currently has two products awaiting phase II approval - Androxal and Proellex, both of which are... Repros Therapeutics' Turnaround... >>

View all posts about Repros Therapeutics (RPRX)

Repros Therapeutics (RPRX) Company Overview

There is no analysis for RPRX yet. But you can go to Wikinvest to help create one!

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates